Aim & Scope
Cancer Research and Cell Development (ISSN: 3066-4861) is an international, Open Access publisher of peer-reviewed journals encompassing a broad spectrum of scientific research and technological disciplines.
Cancer Research and Cell Development (ISSN: 3066-4861) is originated with a rigid commitment of serving the scientific and research community by inviting innovations and a vision to encourage the existing scientists, experts and young scientists to enlighten the common society, encompassing a broad spectrum of scientific research and technological disciplines.
Cancer Research and Cell Development (ISSN: 3066-4861) is an Open Access single blinded peer-reviewed medical journal, publish original research articles, review papers, clinical studies, case reports, editorials, and perspectives etc. It seeks support from individuals, institutes, libraries, universities, funding agencies, and others.
Cancer Research and Cell Development (ISSN: 3066-4861) deals with the disorders and complications that are related to cancer biology, tumor progression, cellular mechanisms, and advances in cancer diagnosis and therapy.
The current research in Cancer Research and Cell Development (ISSN: 3066-4861) involves in the development of new techniques to minimize these ailments and provides knowledge for researchers, practitioners and even for common people.
Cancer Research and Cell Development (ISSN:3066-4861) accepts the articles in the fields of: General Cancer Biology, Oncology, Carcinogenesis, Tumor, Cancer Stem Cells, Metastasis, Angiogenesis, Tumor Immunology, Cancer Biomarkers, Epigenetics in Cancer, Tumor Heterogeneity, Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Pancreatic Cancer, Brain Tumors (Glioblastoma), Hematological Malignancies (Leukemia, Lymphoma, Myeloma), Skin Cancer (Melanoma, Non-Melanoma), Liver Cancer (Hepatocellular Carcinoma), Early Cancer Detection, Liquid Biopsy, Circulating Tumor Cells (CTCs), Radiomics & Imaging Biomarkers, Molecular Diagnostics, AI in Cancer Diagnosis, Next-Generation Sequencing (NGS) in Oncology, Cancer Genomics, Chemotherapy, Radiotherapy, Immunotherapy (Checkpoint Inhibitors, CAR-T Cells), Targeted Therapy, Hormone Therapy, Gene Therapy in Cancer, Precision Medicine in Oncology, Nanomedicine for Cancer Treatment, Cancer Vaccines, Drug Resistance in Cancer, Lifestyle & Cancer Risk, Smoking & Cancer, Obesity and Cancer, Environmental Carcinogens, HPV & Cancer, Genetic Susceptibility to Cancer, Artificial Intelligence in Oncology, Exosomes in Cancer, Organoids & 3D Cancer Models, Single-Cell RNA Sequencing in Cancer, Microbiome & Cancer, Cancer Epidemiology, Clinical Trials in Oncology, Ethical Issues in Cancer Research, Global Cancer Burden.
Authors can contribute their valuable submission through online and/or to info@mediresonline.org
Lung Cancer: is a malignant tumor that develops in the lungs, often linked to smoking, environmental exposures, or genetic factors. It is classified as small cell or non-small cell lung cancer. Symptoms include persistent cough, chest pain, and shortness of breath. Early diagnosis and treatment improve survival and quality of life.
Breast Cancer: is a malignant tumor that develops in the breast tissue, usually in the ducts or lobules. It can spread to nearby lymph nodes or other organs if untreated. Early detection through screening and timely treatment improves survival and outcomes. Cancer Biomarkers are biological molecules found in blood, tissues, or other body fluids that indicate the presence or progression of cancer. They help in early detection, diagnosis, and monitoring treatment response.
Cancer biomarkers: are crucial for personalized therapy and improving patient outcomes.
Oncology: is the branch of medicine that deals with the study, diagnosis, and treatment of cancer. It involves managing therapies like surgery, chemotherapy, and radiotherapy. Oncology also focuses on improving patient survival and quality of life.
Global Cancer: refers to the worldwide burden of cancer, including incidence, mortality, and prevalence. It highlights variations in cancer types, risk factors, and healthcare access across regions. Understanding global cancer trends aids in prevention, early detection, and improving treatment strategies.
Chemotherapy: is a cancer treatment that uses drugs to kill or stop the growth of rapidly dividing cells. It can be administered orally, intravenously, or through other routes. Chemotherapy is used alone or with surgery and radiotherapy to treat various cancers. It may cause side effects due to its impact on healthy cells.
Radiotherapy: is a medical treatment that uses high-energy radiation to kill or damage cancer cells. It targets tumors while minimizing damage to surrounding healthy tissue. Radiotherapy can be used alone or alongside surgery and chemotherapy to control or eliminate cancer.
Early Cancer Detection: involves identifying cancer at an initial stage before symptoms appear. It uses screening methods like imaging, blood tests, and biopsies. Early detection increases treatment success and improves survival rates.
Colorectal Cancer: is a malignant tumor that develops in the colon or rectum. It often arises from polyps and may cause changes in bowel habits or blood in stool. Early detection through screening improves treatment outcomes and survival.
Cancer Research: is the scientific study focused on understanding the causes, development, and progression of cancer. It aims to develop new diagnostics, treatments, and preventive strategies. Research spans molecular biology, clinical trials, and epidemiology. Advancements in cancer research improve patient outcomes and guide personalized therapies.
